NOVAVAX INC — Director's Dealing 2016

Mar 17, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2016-03-15

Reporting Person: YOUNG JAMES F (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-03-15	Stock Option (Right to buy)	$4.99	A	100000	Acquired	2026-03-15	Common Stock (100000)	Direct

Footnotes

F1: One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") 2015 Stock Incentive Plan will vest six (6) months from the March 15, 2016 grant date subject to continued service on the Company's Board of Directors through the vesting date.